Navigation Links
Echo Therapeutics, Inc. Announces 2011 Financial Results
Date:3/16/2012

f="http://www.twitter.com/echotx">www.twitter.com/echotx
- Join us on Facebook at www.facebook.com/echotxEcho Therapeutics, Inc.Condensed Consolidated Balance SheetsDecember 31,2011December 31,2010ASSETSCurrent Assets:Cash and cash equivalents

$
8,995,571$
,342,044Other current assets

567,940621,693Total current assets

9,563,5111,963,737Net property and equipment (including assets under capitalized leases)

317,73148,034Other Assets:Intangible assets, net of accumulated amortization

9,625,0009,625,000Restricted cash, deposits and other assets

20,565275,499Total other assets

9,645,5659,900,499Total assets

$  19,526,807$  11,912,270LIABILITIES AND STOCKHOLDERS' EQUITYCurrent Liabilities:Accounts payable

$
365,298$
5,634Deferred revenue

123,708405,454Derivative warrant liability

1,035,3371,544,996Accrued expenses and other liabilities

968,120565,546Total current liabilities

2,492,4633,121,630Deferred revenue, notes payable and capital lease obligation, net of current portion

65,75588,356Total liabilities

2,558,2183,209,986CommitmentsStockholders' Equity:Perpetual redeemable preferred stock, Series B

-2Convertible preferred stock, Series C & D

30,16049Common stock

385,442311,264Additional paid-in capital

98,116,32779,646,385Common stock subscribed for but not paid for or issued

6,667285,000Accumulated deficit

(81,570,007)(71,540,416)Total stockholders' equity

16,968,5898,702,284Total liabilities and stockholders' equity

$  19,526,807$  11,912,270Condensed Consolidated Statements of OperationsYears Ended December 31,20112010Licensing revenue

$
302,059$
225,868Other revenue

145,152202,592Total revenues

447,211428,460Operating Expenses:Research and development

3,796,1272,578,852Selling, general a
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...
(Date:5/21/2013)... , May 21, 2013  Janssen R&D Ireland ... from the global Phase 3 PROMISE study demonstrating ... (TMC435) led to sustained virologic response 12 weeks ... percent of treatment-experienced genotype 1 chronic hepatitis C ... stages of liver fibrosis, when administered once daily ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Reimbursement Scenario for Medical Devices in ...   Changing Regulatory ... the US Market   ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
... M. Bergman, Chairman and Chief Executive Officer of ... the largest provider of health care products and ... impact of a world without effective antibiotics before ... leaders of society at the World Economic Forum,s ...
... 2012  Vision-Sciences, Inc. (NASDAQ:  VSCI), a leading provider ... disposable EndoSheath® technology, today announced its participation at ... TIME: 2:30 PM EST ... "register/ watch event now" button. This ...
Cached Medicine Technology:Henry Schein's Chairman and CEO Addresses the World Economic Forum 2Henry Schein's Chairman and CEO Addresses the World Economic Forum 3Vision-Sciences, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 2nd 2
(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 ... Care, ScripNet and Procura Management, today announced that ... Award at Catamaran’s client advisory meeting. Conferred ... has partnered with Catamaran to create cutting edge ... This year, Healthcare Solutions was recognized for its ...
(Date:5/21/2013)... May 21, 2013 Two-thirds of patients ... cell lung cancer reported that they engage in at ... use, according to new findings from the National ... Kantar Health . The research will be presented today ... Society for Pharmacoeconomics and Outcomes Research) in New Orleans. ...
(Date:5/21/2013)... 2013 A plastic surgery Internet ... plastic surgery SEO services following an Internet survey. ... name the “Best Plastic Surgery SEO Services”. , ... was predictable. Well-known in the plastic surgery Internet ... than any other selection based on superior client ...
(Date:5/21/2013)... May 21, 2013 It’s nearly summer and ... camp or starting practice for summer or fall sports. ... or sporting activities can begin. , To help parents ... for youth sports or camp physicals at just ... will review a child’s medical history, perform a physical exam ...
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance Sales Representatives and ... Cabos, Mexico, Feb. 23-March 1, 2013, to help renovate Casa ... facility serves meals and provides a social outlet for 45 ... Platinum Vice President, Mike Muench, says that the idea for ... “Platinum got its start selling long-term care insurance ,” ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3
... release is available in French . ... could be closer to reality, thanks to a discovery ... Hospital Research Centre. According to a study published in ... have become the first to clone, produce and purify ...
... patients with weakened immune systems. So it would seem ... prime breeding ground for infections because of the constantly ... whom could be exposed to bacteria and viruses at ... among the most common causes of illness and death ...
... Technology from Xiotech Selected by National Provider ... Minn., March 17 Xiotech Corporation today ... Emprise(TM) 7000 storage system, powered by Intelligent ... virtualization initiative. Milliman Care Guidelines will use ...
... 17 Siemens Energy & Automation, Inc. ... Mass., has selected Simatic(R) PCS 7 Lab ... manage pre- and post-clinical experimental data.(Logo: ... therapeutics based upon their novel polymeric nanoparticle ...
... (Hologic or the Company) (Nasdaq: HOLX ), ... medical imaging systems and surgical products dedicated to serving ... release its second quarter fiscal 2009 operating results on ... with the release, management will host a conference call ...
... Psychiatry , published by Elsevier, is very pleased to ... devoted to fundamental new insights into epigenetics, a field ... produce long-lasting or even heritable changes in gene function ... epigenetics in psychiatry promises several key advances, as noted ...
Cached Medicine News:Health News:Researchers clone key sperm-binding proteins 2Health News:Patient Infection Rates Controlled by Unique Program at Outpatient Cancer Clinic 2Health News:Patient Infection Rates Controlled by Unique Program at Outpatient Cancer Clinic 3Health News:Patient Infection Rates Controlled by Unique Program at Outpatient Cancer Clinic 4Health News:Emprise 7000 Storage System, with ICON Manager and Virtual View Integration, Helps Milliman Care Guidelines Simplify Storage Management 2Health News:Emprise 7000 Storage System, with ICON Manager and Virtual View Integration, Helps Milliman Care Guidelines Simplify Storage Management 3Health News:Emprise 7000 Storage System, with ICON Manager and Virtual View Integration, Helps Milliman Care Guidelines Simplify Storage Management 4Health News:BIND Biosciences To Install First Siemens Simatic(R) PCS 7 Lab Process Control System in the U.S. 2Health News:BIND Biosciences To Install First Siemens Simatic(R) PCS 7 Lab Process Control System in the U.S. 3Health News:Hologic to Release Second Quarter Fiscal 2009 Operating Results on Monday, May 4, 2009 2Health News:Understanding mental illness through gene-environment interactions 2
... long-life Active RFID tags using the wireless ... mobile assets or people, AeroScout enables the ... many different assets for the purpose of ... T2 Tag can be programmed via a ...
... Labels have a direct thermal print ... Tag-it™ HF-I transponder. When processed through ... and other graphics may be printed ... is programmed to the RFID transponder. ...
The PDC Smart® Key Fob can be programmed on demand using a 13.56 MHz RFID reader/writer and is ideal for long-term use applications such as electronic access control or loyalty programs....
... SURGICHIP™ is a patent pending solution ... embedded in a smart label to ... prevent wrong-patient, wrong-site, wrong-procedure surgery. This ... by an orthopedic surgeon with the ...
Medicine Products: